Articles about Seattle biotech

University of Washington and Seattle biotech win $245M patent judgment against Guardant

A Seattle biotech built on University of Washington research has won a $245 million patent judgment against Guardant Health over DNA sequencing technology, with the court also ordering ongoing royalties through 2033. Read More

Juno Therapeutics’ giant new Seattle HQ is designed to destroy cancer

When you walk into Juno Therapeutics‘ new headquarters in Seattle, your eyes are immediately drawn to the view. The office’s… Read More

Why Seattle’s Omeros continues to be dogged by questions over its next big drug

Omeros, one of Seattle’s biggest biotech companies, may have its hands on a lucrative new drug — but questions about… Read More

Study: ID Genomics’ bacteria ‘fingerprinting’ technology helps doctors diagnose infection more accurately

The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it… Read More

New nonprofit lab SoundBio hopes to spark Seattle’s DIY biology community

Despite a vibrant maker culture, and one of the top biotech industries in the nation, Seattle has never had a… Read More

Chinese genomics giant BGI announces new Seattle office

BGI, the Shenzhen, China,-based genomics giant, announced today that it has opened a Seattle office as part of a major expansion… Read More

Seattle just got another publicly traded biotech company

Seattle-based Aptevo Therapeutics completed a spinoff from Emergent BioSolutions Monday, making a debut in the public markets as a standalone company.… Read More